Betahistine hydrochloride is the generic name for the anti vertigo drug SERC. It was first registered in Europe in 1970 for the treatment of Ménière's disease. It is commonly prescribed for people who have balance disorders or to alleviate the vertigo symptoms associated with Ménière's disease.
3 edits since May 19, 2008. Last edited Jul 24, 2008 by Arcadian (275).
This Compound Monograph is licensed under the GNU Free Documentation License and uses material from the Wikipedia article Betahistine. See this site's terms for details.